Anna Kołcz

Anna Kołcz

Auto-generated profile, based on publicly available information

Anna Kołcz

School of Medicine, Medical University of Silesia, Poniatowskiego 15, 40-055 Katowice, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
KOKarolina Osińska
Karolina Osińska
AMAgnieszka Morawa
Agnieszka Morawa
MSMarcin Krzysztof Schulz
Marcin Krzysztof Schulz
DSDawid Studziński
Dawid Studziński
AKAnna Kołcz
Anna Kołcz
IOIzabela Ochońska
Izabela Ochońska
Introduction and Objective: The prevalence of maternal overweight and obesity has increased dramatically worldwide, posing significant risks for offspring health. Maternal obesity has been associated with multisystemic consequences, including metabolic, cardiovascular, neuroendocrine, renal, and immune disturbances. This review aims to synthesize current evidence on the impact of maternal obesity on offspring health and to identify potential mechanisms underlying these effects. Methods: A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science for studies published up to 2026. Both human epidemiological studies and experimental animal models were included to evaluate the effects of maternal obesity on offspring outcomes. Keywords included “maternal obesity”, “offspring health”, “developmental programming”, “metabolic disorders”, “neurodevelopment”, and “immunology”. Relevant studies were critically assessed, with particular focus on mechanisms, sex-specific effects, and long-term consequences. Results / Methodology: Evidence indicates that maternal obesity programs offspring health through multiple pathways, including altered metabolism, epigenetic modifications, inflammatory processes, and microbiome-mediated effects. Offspring of obese mothers exhibit higher risk of hypertension, insulin resistance, type 2 diabetes, dyslipidemia, impaired renal development, neurodevelopmental and behavioral disorders, and immune dysregulation. These effects are often sex-specific and may persist throughout childhood and adulthood. Both preconception and gestational interventions, including weight management and lifestyle optimization, can partially mitigate these risks. Conclusion: Maternal obesity is a major determinant of long-term multisystem health outcomes in offspring. Understanding the mechanisms of developmental programming is essential for developing preventive strategies, emphasizing the importance of maternal health optimization before and during pregnancy.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
WSWiktoria Szkatuła
Wiktoria Szkatuła
MSMarcin Krzysztof Schulz
Marcin Krzysztof Schulz
AMAgnieszka Morawa
Agnieszka Morawa
DSDawid Studziński
Dawid Studziński
KOKarolina Osińska
Karolina Osińska
AKAnna Kołcz
Anna Kołcz
Introduction: Hypertrophic cardiomyopathy (HCM) is an inherited condition characterized by sarcomeric hypercontractility, leading to dynamic left ventricular outflow tract (LVOT) obstruction in approximately 70% of patients. Mavacamten, a first-in-class selective cardiac myosin inhibitor, addresses the underlying molecular cause by reducing excessive actin-myosin cross-bridge formation. Aim: To evaluate the clinical efficacy and safety of mavacamten in symptomatic obstructive HCM (oHCM) using data from randomized trials and real-world studies. Methods: A systematic search of PubMed, Embase, and Cochrane Library identified 110 publications. Following predefined criteria, 44 studies were included in the final analysis, including pivotal phase III trials (EXPLORER-HCM, VALOR-HCM) and long-term extensions. Results: Mavacamten demonstrated a significant reduction in LVOT gradients (mean reduction of ~47 mmHg in EXPLORER-HCM) and improved quality of life, with KCCQ-CSS scores increasing by an average of 14.2 points. Between 60% and 80% of patients achieved ≥1 NYHA functional class improvement. In the VALOR-HCM trial, approximately 90% of patients avoided invasive septal reduction therapy (SRT) through 128 weeks. The primary safety concern was a transient reduction in LVEF (<50%) occurring in 5–14% of patients, which was typically reversible with dose titration. Conclusion: Mavacamten is a transformative non-invasive therapy that shifts oHCM management from palliative care to mechanism-targeted treatment. While highly effective in improving hemodynamics and functional capacity, rigorous echocardiographic monitoring remains mandatory to ensure safety regarding systolic function.

21 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MSMarcin Krzysztof Schulz
Marcin Krzysztof Schulz
MKMichał Kulczak
Michał Kulczak
DSDawid Studziński
Dawid Studziński
AKAnna Kołcz
Anna Kołcz
AMAgnieszka Morawa
Agnieszka Morawa
KOKarolina Osińska
Karolina Osińska
Advanced heart failure (AHF) constitutes a terminal expression of cardiovascular disease, associated with severe, refractory symptoms and high mortality despite optimized medical therapy. Levosimendan, a first-in-class inodilator, addresses this challenge, acting as a calcium sensitizer and potassium channel opener. Its unique tripartite mechanism provides positive inotropy independently of the cAMP pathway, critically avoiding increased intracellular calcium or myocardial oxygen demand. The active metabolite, OR-1896, ensures prolonged hemodynamic benefits lasting up to two weeks, supporting intermittent, outpatient bridging strategies. This systematic literature review synthesized current evidence by applying a rigorous search strategy across biomedical databases, resulting in the inclusion of 32 scientific publications encompassing high-level evidence such as meta-analyses, randomized controlled trials (RCTs), and cohort studies. Pooled analyses suggest that repetitive levosimendan administration significantly improves Left Ventricular Ejection Fraction (LVEF), reduces NT-proBNP levels, and is associated with a reduced risk of all-cause mortality (RR 0.60). Furthermore, it confers vital organoprotective effects, notably improving renal function in patients awaiting heart transplantation (HTx), and its preoperative use as a "bridge to transplant" (BTT) is deemed safe. Despite compelling data from small RCTs (e.g., LION-HEART), the field requires larger, definitive studies—such as the ongoing LEIA-HF trial—to establish the precise role of levosimendan in contemporary AHF management.

30 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
KOKarolina Osińska
Karolina Osińska
MSMarcin Krzysztof Schulz
Marcin Krzysztof Schulz
AMAgnieszka Morawa
Agnieszka Morawa
DSDawid Studziński
Dawid Studziński
AKAnna Kołcz
Anna Kołcz
MKMichał Kulczak
Michał Kulczak
The incidence of autoimmune diseases is increasing year by year, especially in Western societies. Many factors, both genetic and environmental, are involved, and vitamin D (vD, 25(OH)D3) deficiency is considered to be one of the key factors. However, the precise etiopathogenesis of autoimmune disorders is still not fully understood, which is also reflected in the limitation of therapeutic possibilities. Recently, there has been a growing interest in the role of vitamin D in alleviating autoimmunological processes, as vD has the ability to stimulate or inhibit virtually every stage of the immune response through its vitamin D receptor (VDR), expressed on immune cells. Innate and adaptive immune system and endothelial membrane stability. This allows us to define this vitamin as a strong immunomodulator in terms of both innate and acquired immunity. The aim of this paper is to present the pathophysiology of selected autoimmune diseases and to demonstrate the modifying properties of vitamin D on the immune system. Our review also demonstrates the scale of deficiency, both in the general population and among individuals diagnosed with autoimmune disease.

24 May 2026 in Quality in Sport
Verified
Journal Article
Open access
DSDawid Studziński
Dawid Studziński
WSWiktoria Szkatuła
Wiktoria Szkatuła
KOKarolina Osińska
Karolina Osińska
AKAnna Kołcz
Anna Kołcz
MKMichał Kulczak
Michał Kulczak
IOIzabela Ochońska
Izabela Ochońska
This systematic review formulates an organizational service framework integrating clinical urological data with sports management practices to mitigate disease-induced dropout among aging male athletes. Following PRISMA guidelines, a systematic search of PubMed (2021–2026) yielded 22 primary open-access articles evaluating physical activity, sedentary behaviors, and male urological or renal outcomes. High-volume cohort data confirms a robust inverse relationship between regular physical activity and the severity of lower urinary tract symptoms and erectile dysfunction, though extreme training volumes display a non-linear risk threshold. In clinical rehabilitation phases, supervised technological exercises paired with behavioral compliance models significantly accelerate post-surgical continence recovery. Longitudinally, overactive bladder symptoms serve as independent predictors of upper-limb grip strength decline and physical frailty. Sports enterprises can optimize service quality and member retention by moving from generic configurations toward age-appropriate, urologically sustainable exercise designs. Practical administrative interventions include expanding facility restroom accessibility to reduce public anxiety and embedding non-invasive urological screening metrics into routine physical assessments to preserve lifelong functional longevity.

18 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WSWiktoria Szkatuła
Wiktoria Szkatuła
MSMarcin Krzysztof Schulz
Marcin Krzysztof Schulz
KOKarolina Osińska
Karolina Osińska
MKMichał Kulczak
Michał Kulczak
AKAnna Kołcz
Anna Kołcz
SMSonia Mojzyk
Sonia Mojzyk
Sports-related sudden cardiac arrest (SRSCA) is defined as a natural out-of-hospital collapse of presumed cardiac origin occurring during or within one hour of moderate-to-vigorous physical exercise. Despite the well-documented cardiovascular benefits of physical activity, vigorous exertion can transiently trigger life-threatening arrhythmias in vulnerable individuals, a phenomenon known as the "paradox of exercise". This scientific review aims to evaluate the combined influence of age and sex on the risk and clinical presentation of SRSCA by synthesizing high-quality evidence from contemporary literature, including 37 original research articles drawn from international registries such as the NCAA, FIFA, and ESCAPE-NET. The analysis reveals a striking and consistent male predominance, with men accounting for 90% to 98% of cases across various registries, while women exhibit a 10- to 13-fold lower incidence rate. Furthermore, the underlying pathological substrates shift significantly with age; inherited or congenital structural diseases like hypertrophic cardiomyopathy and coronary artery anomalies predominate in athletes under 35, whereas atherosclerotic coronary artery disease is the primary cause in those over 35. Survival rates following SRSCA are notably favorable compared to non-sports cardiac arrests, ranging from 45% to over 90% in organized settings, largely due to the witnessed nature of these events and the rapid utilization of automated external defibrillators (AEDs), which is associated with survival as high as 86%. Consequently, reducing the burden of sudden death requires a two-tier strategy: primary prevention through preparticipation screening initiated around age 12 to detect phenotypic manifestations of disease, and secondary prevention via robust emergency preparedness, including mandatory AED access and rehearsed emergency action plans at all sporting venues.